UPDATE 1-Sika posts 21.8 pct rise in 2016 profit, to propose higher dividend
Feb 24 Speciality chemicals maker Sika on Friday posted a 21.8 percent rise in net profit for 2016 and said it will propose an increased dividend for 2016.
Jan 5 Mirati Therapeutics Inc :
* Mirati Therapeutics provides update on glesatinib and sitravatinib clinical trials and pipeline programs
* Mirati therapeutics inc - early results from trial show clear evidence of tumor responses in NSCLC patients exhibiting ret fusion mutations
* Says expects to provide an additional update on glesatinib program in second half of 2017
* Says expects to provide an additional update on sitravatinib program in Q3 2017 Source text for Eikon: Further company coverage:
KUALA LUMPUR, Feb 24 Malaysian authorities will sweep the international airport and other locations for radioactive material, the police chief said on Friday, following the murder of Kim Jong Nam in which VX nerve agent, a highly toxic chemical, was used.
Feb 23 Speciality chemicals maker Sika, which remains locked in a bitter takeover battle with France's Saint-Gobain, on Friday posted a 21.8 increase in net profit for 2016.